Hansoh Pharma Sustainability Profile
Hansoh Pharmaceutical Group Company Limited, commonly known as Hansoh Pharma, is a leading biopharmaceutical enterprise headquartered in China. Established in 1995, the company has made significant strides in the pharmaceutical industry, focusing on the research, development, manufacturing, and marketing of innovative medicines. With a strong presence in major operational regions across Asia and beyond, Hansoh Pharma is dedicated to addressing unmet medical needs. The company’s core business areas include oncology, central nervous system disorders, and autoimmune diseases, with a portfolio of unique products that leverage advanced biopharmaceutical technologies. Notably, Hansoh Pharma has achieved recognition for its commitment to quality and innovation, positioning itself as a key player in the global market. With numerous accolades and a robust pipeline of therapies, Hansoh Pharma continues to contribute to the advancement of healthcare solutions.
DitchCarbon Score
How does Hansoh Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hansoh Pharma's score of 5 is lower than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hansoh Pharma's reported carbon emissions
Hansoh Pharma, headquartered in China (CN), currently does not have publicly available carbon emissions data or specific climate commitments. There are no reported emissions figures, reduction targets, or initiatives related to the Science Based Targets initiative (SBTi) or other climate pledges. As such, the company appears to be in the early stages of developing its climate strategy and emissions reporting. Without specific data or commitments, it is challenging to assess their environmental impact or sustainability efforts at this time.
How Carbon Intensive is Hansoh Pharma's Industry?
How Carbon Intensive is Hansoh Pharma's Location?
Hansoh Pharma's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Hansoh Pharma has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
